Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-Severe Plaque Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02445807
What this trial is testing

The Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Chronic Stable Plaque Psoriasis
Promius Pharma, LLC 265
Large-scale testing (Phase 3)Study completedNCT01806597
What this trial is testing

Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis

Who this might be right for
Moderate to Severe Palmoplantar Psoriasis
Novartis Pharmaceuticals 205
Testing effectiveness (Phase 2)Ended earlyNCT00954915
What this trial is testing

Safety Study of the Monoclonal Antibody Teplizumab (MGA031) in Subjects With Moderate or More Severe Psoriasis

Who this might be right for
Psoriasis
MacroGenics 1
Testing effectiveness (Phase 2)Study completedNCT05344248
What this trial is testing

Safety, Tolerance, Efficacy and Pharmacokinetics of JS005 Multiple Dosing

Who this might be right for
Moderate to Severe Psoriasis
Shanghai Junshi Bioscience Co., Ltd. 183
Testing effectiveness (Phase 2)Study completedNCT03591887
What this trial is testing

Evaluate ABY-035 in Subjects With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Affibody 108
Not applicableStudy completedNCT01425138
What this trial is testing

Systematic Review And Meta-Analysis Of Psoriasis Treatments.

Who this might be right for
Psoriasis
Pfizer 1
Testing effectiveness (Phase 2)Study completedNCT01622348
What this trial is testing

Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Actively Extending Plaque PsoriasisModerate to Severe Plaque Psoriasis
Idera Pharmaceuticals, Inc. 44
Large-scale testing (Phase 3)Study completedNCT01206387
What this trial is testing

Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT00645814
What this trial is testing

Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 148
Large-scale testing (Phase 3)Study completedNCT00333034
What this trial is testing

Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Psoriasis

Who this might be right for
Psoriasis
Wyeth is now a wholly owned subsidiary of Pfizer 120
Large-scale testing (Phase 3)Active Not RecruitingNCT06934226
What this trial is testing

Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 752
Post-approval studies (Phase 4)Ended earlyNCT01543204
What this trial is testing

Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab

Who this might be right for
Psoriasis
Amgen 64
Testing effectiveness (Phase 2)Study completedNCT00428974
What this trial is testing

Safety and Efficacy Study of CF101 to Treat Psoriasis

Who this might be right for
Plaque Psoriasis
Can-Fite BioPharma 76
Testing effectiveness (Phase 2)Study completedNCT01483599
What this trial is testing

Evaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Janssen Inc. 293
Not applicableUnknownNCT02174367
What this trial is testing

An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis

Who this might be right for
Psoriasis ChronicLiver FibrosisFatty Liver+1 more
King's College London 400
Not applicableActive Not RecruitingNCT06142357
What this trial is testing

Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Novartis Pharmaceuticals 199
Post-approval studies (Phase 4)UnknownNCT03307447
What this trial is testing

Secukinumab Therapy for the Treatment of Moderate to Severe Plaque Psoriasis With Response Monitoring Using Optical Coherence Tomography (OCT).

Who this might be right for
Psoriasis Vulgaris
Narrows Institute for Biomedical Research 30
Testing effectiveness (Phase 2)Study completedNCT06061471
What this trial is testing

To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
PsoriasisSkin Diseases
Akeso 454
Very early researchLooking for participantsNCT07337434
What this trial is testing

To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital

Who this might be right for
Chronic Plaque Psoriasis
Syeda Sana Zaman 106
Testing effectiveness (Phase 2)Study completedNCT02576678
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 42
Next Page